“FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study”. 2018. SKIN The Journal of Cutaneous Medicine 2 (December): S56. https://doi.org/10.25251/skin.2.supp.56.